BioCardia Inc. – Filings and Transcripts

NASDAQ: BCDA
Share price (6/3/26): $0.87
Market cap (6/3/26): $9.948 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2 2025 – amended

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement with pricing info

Initial registration of new securities – amended

Ownership Filter

News Filter

Announces Japan Pmda Record of Advice Supports Regulatory Submission for Approval of Cardiamp Cell Therapy for Ischemic Heart Failure Submission Anticipated in Q4 2026

Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance With Reduced Angina Frequency

Reports First Quarter 2026 Business Highlights and Financial Results

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Notice of effectiveness

Notice of effectiveness